Please login to the form below

Not currently logged in
Email:
Password:

Santhera

This page shows the latest Santhera news and features for those working in and with pharma, biotech and healthcare.

Encouraging data for GenSight’s blinding retinal disease gene therapy

Encouraging data for GenSight’s blinding retinal disease gene therapy

If approved, the gene therapy would compete with Santhera's Raxone, which became the first approved treatment for LHON in Europe in 2015.

Latest news

More from news
Approximately 5 fully matching, plus 10 partially matching documents found.

Latest appointments

  • Shires's Jeffrey Jonas to lead Sage Shires's Jeffrey Jonas to lead Sage

    The other key appointments are AstraZeneca's Stephen Kanes as chief medical officer and Santhera's Kimi Iguchi as chief financial officer. ... Iguchi joins from her role as chief operating officer, North America, for Santhera.

  • Santhera CEO Klaus Schollmeier joins SuppreMol Santhera CEO Klaus Schollmeier joins SuppreMol

    He has experience at ING BHF-Bank, BASF, Knoll and Abbott. Former CEO of Santhera Pharmaceuticals Klaus Schollmeier has joined Germany-based biopharma SuppreMol as CEO. ... Dr Schollmeier (pictured right) had served as CEO of Santhera since its formation

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Healthcircle

    Novo Nordisk. Otsuka. Pfizer. Roche. Santen. Santhera. Schwabe. Pelviva. Unicough.

  • Solaris Health

    GlaxoSmithKline. Ipsen. Meda. PM Society. Santhera. Visufarma. See our Thought Leadership article reviewing pressures at both end of the cost spectrum and considering the likely impact on clinicians and patients.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...

Infographics